Dopamine release regulation by astrocytes during cerebral ischemia

Neurobiology of Disease

Volumn 58, Issue , 2013, Pages 231-241

  Oliva, Idaira ^a   Fernández, Miriam ^a   Martín, Eduardo D ^a  

^a UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Dopamine transporters; Excitotoxicity; Fast scan cyclic voltammetry; Glutamate transporters; Striatum

Indexed keywords

CALCIUM; DOPAMINE; DOPAMINE TRANSPORTER; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROPIDIUM IODIDE; TRIPHENYLTETRAZOLIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN DAMAGE; BRAIN ISCHEMIA; BRAIN SLICE; CALCIUM SIGNALING; CELL VACUOLE; CELL VIABILITY; CONTROLLED STUDY; CORPUS STRIATUM; CYCLIC POTENTIOMETRY; DOPAMINE RELEASE; EVOKED RESPONSE; EXOCYTOSIS; IN VITRO STUDY; MOUSE; NERVE CELL LESION; NERVE FUNCTION; NERVE POTENTIAL; NONHUMAN; PRIORITY JOURNAL;

DOPAMINE TRANSPORTERS; EXCITOTOXICITY; FAST-SCAN CYCLIC VOLTAMMETRY; GLUTAMATE TRANSPORTERS; STRIATUM;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; ASPARTIC ACID; ASTROCYTES; CALCIUM; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; EXOCYTOSIS; FUNCTIONAL LATERALITY; HYPOXIA-ISCHEMIA, BRAIN; MICE; MICE, INBRED C57BL; NEUROTOXICITY SYNDROMES; OXIDOPAMINE; PIPERAZINES; TETRODOTOXIN; TIME FACTORS;

EID: 84880166426     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.06.007     Document Type: Article

References (65)

1. Araque A., Parpura V., Sanzgiri R.P., Haydon P.G. Glutamate-dependent astrocyte modulation of synaptic transmission between cultured hippocampal neurons. Eur. J. Neurosci. 1998, 10:2129-2142.
2. Araque A., Li N., Doyle R.T., Haydon P.G. SNARE protein dependent glutamate release from astrocytes. J. Neurosci. 2000, 20:666-673.
3. Benedek A., Moricz K., Juranyi Z., Gigler G., Levay G., Harsing L.G., Matyus P., Szenasi G., Albert M. Use of TTC staining for the evaluation of tissue injury in the early phases of reperfusion after focal cerebral ischaemia in rats. Brain Res. 2006, 1116:159-165.
4. Benfenati F., Pich E.M., Grimaldi R., Zoli M., Fuxe K., Toffano G., Agnati L.F. Transient forebrain ischemia produces multiple deficits in dopamine D1 transmission in the lateral neostriatum of the rat. Brain Res. 1989, 498:376-380.
5. Bergles D.E., Jahr C.E. Glial contribution to glutamate uptake at Schaffer collateral-commissural synapses in the hippocampus. J. Neurosci. 1998, 18:7709-7716.
6. Bozzo L., Chatton J.Y. Inhibitory effects of (2S, 3S)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy] aspartate (TFB-TBOA) on the astrocytic sodium responses to glutamate. Brain Res. 2010, 1316:27-34.
7. Brannan T., Weinberger J., Knott P., Taff I., Kaufmann H., Togasaki D., Nieves-Rosa J., Maker H. Direct evidence of acute, massive striatal dopamine release in gerbils with unilateral strokes. Stroke 1987, 18:108-110.
8. Büyükuysal R.L., Mete B. Anoxia-induced dopamine release from rat striatal slices: involvement of reverse transport mechanism. J. Neurochem. 1999, 72:1507-1515.
9. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
10. Danton G.H., Dietrich W.D. Inflammatory mechanisms after ischaemia and stroke. J. Neuropathol. Exp. Neurol. 2003, 62:127-136.
11. Ding S., Wang T., Cui W., Haydon P.G. Photothrombosis ischemia stimulates a sustained astrocytic Ca2+ signaling in vivo. Glia 2009, 57:767-776.
12. Doyle K.P., Simon R.P., Stenzel-Poore M.P. Mechanisms of ischemic brain damage. Neuropharmacology 2008, 55:310-318.
13. Farber K., Pannasch U., Kettenmann H. Dopamine and noradrenaline control distinct functions in rodent microglial cells. Mol. Cell. Neurosci. 2005, 29:128-138.
14. Fellin T., Pascual O., Gobbo S., Pozzan T., Haydon P.G., Carmignoto G. Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. Neuron 2004, 43:729-743.
15. Globus M.Y., Busto R., Dietrich W.D., Martinez E., Valdes I., Ginsberg M.D. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis. J. Neurochem. 1988, 51:1455-1464.
16. Hoyt K.R., Reynolds I.J., Hastings T.G. Mechanisms of dopamine-induced cell death in cultured rat forebrain neurons: interactions with and differences from glutamate-induced cell death. Exp. Neurol. 1997, 143:269-281.
17. Kang J., Jiang L., Goldman S.A., Nedergaard M. Astrocyte-mediated potentiation of inhibitory synaptic transmission. Nat. Neurosci. 1998, 1:683-692.
18. 3H]-dopamine from rat striatal slices. Clin. Exp. Pharmacol. Physiol. 1995, 22:301-302.
19. Kostandy B.B. The role of glutamate in neuronal ischemic injury: the role of spark in fire. Neurol. Sci. 2012, 33:223-237.
20. Largo C., Cuevas P., Somjen G.G., Martin del Rio R., Herreras O. The effect of depressing glial function in rat brain in situ on ion homeostasis, synaptic transmission, and neuron survival. J. Neurosci. 1996, 16:1219-1229.
21. Li S., Mealing G.A., Morley P., Stys P.K. Novel injury mechanism in anoxia and trauma of spinal cord white matter: glutamate release via reverse Na+-dependent glutamate transport. J. Neurosci. 1999, 19:RC16.
22. Lieb K., Andrae J., Reisert I., Pilgrim C. Neurotoxicity of dopamine and protective effects of the NMDA receptor antagonist AP-5 differ between male and female dopaminergic neurons. Exp. Neurol. 1995, 134:222-229.
23. Link E., Edelmann L., Chou J.H., Binz T., Yamasaki S., Eisel U., Baumert M., Südhof T.C., Niemann H., Jahn R. Tetanus toxin action: inhibition of neurotransmitter release linked to synaptobrevin proteolysis. Biochem. Biophys. Res. Commun. 1992, 189:1017-1023.
24. Liu Q.S., Xu Q., Arcuino G., Kang J., Nedergaard M. Astrocyte-mediated activation of neuronal kainate receptors. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:3172-3177.
25. Longuemare M.C., Swanson R.A. Excitatory amino acid release from astrocytes during energy failure by reversal of sodium-dependent uptake. J. Neurosci. Res. 1995, 40:379-386.
26. Macklis J.D., Madison R.D. Progressive incorporation of propidium iodide in cultured mouse neurons correlates with declining electrophysiological status: a fluorescence scale of membrane integrity. J. Neurosci. Meth. 1990, 31:43-46.
27. Malarkey E.B., Parpura V. Mechanisms of glutamate release from astrocytes. Neurochem. Int. 2008, 52:142-154.
28. Marie C., Mossiat C., Beley A., Bralet J. Alpha-methyl-para-tyrosine pretreatment protects from striatal neuronal death induced by four-vessel occlusion in the rat. Neurochem. Res. 1992, 17:961-965.
29. Martín E.D., Buño W. Caffeine-mediated presynaptic long-term potentiation in hippocampal CA1 pyramidal neurons. J. Neurophysiol. 2003, 89:3029-3038.
30. Martin L.L., Lee G.E., Lee T.B., Rush D.K., Wilmot C.A., Paulus E., Elben U., Grome J.J., Porsche-Wiebking E., Rudolphi K.A., et al. Synthesis, resolution, and SAR of (+/-)-2-amino-N-methyl-alpha-(3-methyl-2-thienyl) benzeneethanamine+++ and related analogs as noncompetitive NMDA antagonists with neuroprotective properties. J. Med. Chem. 1994, 37:3008-3015.
31. Martín E.D., Fernández M., Perea G., Pascual O., Haydon P.G., Araque A., Ceña V. Adenosine released by astrocytes contributes to hypoxia-induced modulation of synaptic transmission. Glia 2007, 55:36-45.
32. Mathews K.S., McLaughlin D.P., Ziabari L.H., Toner C.C., Street P.C., Hisgrove E., Bezzina E.L., Stamford J.A. Rapid quantification of ischaemic injury and cerebroprotection in brain slices using densitometric assessment of 2,3,5-triphenyltetrazolium chloride staining. J. Neurosci. Methods 2000, 102:43-51.
33. Mennerick S., Benz A., Zorumski C.F. Components of glial responses to exogenous and synaptic glutamate in rat hippocampal microcultures. J. Neurosci. 1996, 16:55-64.
34. Milusheva E., Doda M., Pasztor E., Lajtha A., Sershen H., Vizi E.S. Regulatory interactions among axon terminals affecting the release of different transmitters from rat striatal slices under hypoxic and hypoglycemic conditions. J. Neurochem. 1992, 59:946-952.
35. Mitani A., Tanaka K. Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J. Neurosci. 2003, 23:7176-7182.
36. Nedergaard M., Dirnagl U. Role of glial cells in cerebral ischemia. Glia 2005, 50:281-286.
37. Nemeth G., Cintra A., Herb J.M., Ding A., Goldstein M., Agnati L.F., Hoyer S., Fuxe K. Changes in striatal dopamine neurohistochemistry and biochemistry after incomplete transient cerebral ischemia in the rat. Exp. Brain Res. 1991, 86:545-554.
38. Nishizawa Y. Glutamate release and neuronal damage in ischemia. Life Sci. 2001, 69:369-381.
39. Ooboshi H., Sadoshima S., Yao H., Nakahara T., Uchimura H., Fujishima M. Inhibition of ischemia-induced dopamine release by omega-conotoxin, a calcium channel blocker, in the striatum of spontaneously hypertensive rats: in vivo brain dialysis study. J. Neurochem. 1992, 58:298-303.
40. Parpura V., Basarsky T.A., Liu F., Jeftinija K., Jeftinija S., Haydon P.G. Glutamate-mediated astrocyte-neuron signalling. Nature 1994, 369:744-747.
41. Paulsen R.E., Contestabile A., Villani L., Fonnum F. An in vivo model for studying function of brain tissue temporarily devoid of glial cell metabolism: the use of fluorocitrate. J. Neurochem. 1987, 48:1377-1385.
42. Perea G., Araque A. Properties of synaptically evoked astrocyte calcium signal reveal synaptic information processing by astrocytes. J. Neurosci. 2005, 25:2192-2203.
43. Perea G., Araque A. Astrocytes potentiate transmitter release at single hippocampal synapses. Science 2007, 317:1083-1086.
44. Pulsinelli W.A. Selective neuronal vulnerability: morphological and molecular characteristics. Prog. Brain Res. 1985, 63:29-37.
45. Richards D.A., Obrenovitch T.P., Johonson-Mora A., Islekel S., Symon L., Curzon G. Effect of global ischaemia under simulated penumbral conditions on brain monoamine neurochemistry and subsequent neurological and histological deficits. J. Neurochem. 1993, 61:1801-1807.
46. Rogers J., Mastroeni D., Leonard B., Joyce J., Grover A. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?. Int. Rev. Neurobiol. 2007, 82:235-246.
47. Rossi D.J., Oshima T., Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature 2000, 403:316-321.
48. Rossi D.J., Brady J.D., Mohr C. Astrocyte metabolism and signaling during brain ischemia. Nat. Neurosci. 2007, 10:1377-1386.
49. Rothstein J.D., Martin L., Levey A.I., Dykes-Hoberg M., Jin L., Wu D., Nash N., Kuncl R.W. Localization of neuronal and glial glutamate transporters. Neuron 1994, 13:713-725.
50. Rothstein J.D., Dykes-Hoberg M., Pardo C.A., Bristol L.A., Jin L., Kuncl R.W., Kanai Y., Hediger M.A., Wang Y., Schielke J.P., Welty D.F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16:675-686.
51. Sarna G.S., Obrenovitch T.P., Matsumoto T., Symon L., Curzon G. Effect of transient cerebral ischaemia and cardiac arrest on brain extracellular dopamine and serotonin as determined by in vivo dialysis in the rat. J. Neurochem. 1990, 55:937-940.
52. Schiavo G., Benfenati F., Poulain B., Rossetto O., Polverino de Laureto P., DasGupta B.R., Montecucco C. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 1992, 359:832-835.
53. Seki Y., Feustel P.J., Keller R.W., Tranmer B.I., Kimelberg H.K. Inhibition of ischemia-induced glutamate release in rat striatum by dihydrokinate and an anion channel blocker. Stroke 1999, 30:433-440.
54. Shao W., Zhang S.Z., Tang M., Zhang X.H., Zhou Z., Yin Y.Q., Zhou Q.B., Huang Y.Y., Liu Y.J., Wawrousek E., Chen T., Li S.B., Xu M., Zhou J.N., Hu G., Zhou J.W. Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin. Nature 2013, 494:90-94.
55. Sheldon A.L., Robinson M.B. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem. Int. 2007, 51:333-355.
56. Shimamoto K., Sakai R., Takaoka K., Yumoto N., Nakajima T., Amara S.G., Shigeri Y. Characterization of novel l-threo-beta-benzyloxyaspartate derivatives, potent blockers of the glutamate transporters. Mol. Pharmacol. 2004, 65:1008-1015.
57. Stamford J.A., Isaac D., Hicks C.A., Ward M.A., Osborne D.J., O'Neill M.J. Ascorbic acid is neuroprotective against global ischaemia in striatum but not hippocampus: histological and voltammetric data. Brain Res. 1999, 835:229-240.
58. Swanson R.A., Graham S.H. Fluorocitrate and fluoroacetate effects on astrocyte metabolism in vitro. Brain Res. 1994, 664:94-100.
59. Szatkowski M., Attwell D. Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms. Trends Neurosci. 1994, 17:359-365.
60. Takaki J., Fujimori K., Miura M., Suzuki T., Sekino Y., Sato K. l-Glutamate released from activated microglia downregulates astrocytic l-glutamate transporter expression in neuroinflammation: the 'collusion' hypothesis for increased extracellular l-glutamate concentration in neuroinflammation. J. Neuroinflammation 2012, 9:275.
61. Toner C.C., Stamford J.A. Characteristics of the NMDA receptor modulating hypoxia/hypoglycaemia-induced rat striatal dopamine release in vitro. Eur. J. Pharmacol. 1997, 340:133-143.
62. Toner C.C., Stamford J.A. Effects of metabolic alterations on dopamine release in an in vitro model of neostriatal ischaemia. Brain Res. Bull. 1999, 48:395-399.
63. Werling L.L., Hoehner P.J., Hurt K.J., Fox L.G., Blanck T.J., Rosenthal R.E., Fiskum G. Increased activation of l-type voltage-dependent calcium channels is associated with glycine enhancement of N-methyl-d-aspartate-stimulated dopamine release in global cerebral ischemia/reperfusion. J. Neurochem. 1994, 63:215-221.
64. Yin H.Z., Sensi S.L., Ogoshi F., Weiss J.H. Blockade of Ca2+-permeable AMPA/kainate channels decreases oxygen-glucose deprivation-induced Zn2+ accumulation and neuronal loss in hippocampal pyramidal neurons. J. Neurosci. 2002, 22(4):1273-1279.
65. Zhang J.M., Wang H.K., Ye C.Q., Ge W., Chen Y., Jiang Z.L., Wu C.P., Poo M.M., Duan S. ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron 2003, 40:971-982.